RecruitingPhase 3NCT07028853This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.Sponsor: PfizerTroy, MI · +126 more sites
RecruitingPhase 3NCT03678025Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate CancerSponsor: SWOG Cancer Research NetworkAnn Arbor, MI · Brighton, MI · +331 more sites
RecruitingNot applicableNCT06995898The Vanguard Study: Testing a New Way to Screen for CancerSponsor: National Cancer Institute (NCI)Brownstown, MI · Chesterfield, MI · +42 more sites
RecruitingPhase not listedNCT05334069Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionSponsor: Alliance for Clinical Trials in OncologyAlma, MI · Alpena, MI · Ann Arbor, MI · +744 more sites
RecruitingPhase 2NCT06134232Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-TSponsor: DendreonTroy, MI · +30 more sites